Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Leukemia, Myeloid, Acute × Sulfasalazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1 Glioblastoma 1 Epilepsy 1

Interventions

Cytarabine 71 Azacitidine 61 venetoclax 53 fludarabine phosphate 29 fludarabine 29 Decitabine 25 Cyclophosphamide 24 Idarubicin 22 Peripheral Blood Stem Cell Transplantation 20 Filgrastim 20 Mitoxantrone 16 Granulocyte Colony-Stimulating Factor 16 Busulfan 16 Whole-Body Irradiation 14 Etoposide 14 Cyclosporine 14 Mycophenolic Acid 13 Clofarabine 13 Melphalan 12 Tacrolimus 11 Methotrexate 11 Daunorubicin 11 aldesleukin 10 Injections 10 gilteritinib 9 Gemtuzumab 9 decitabine and cedazuridine drug combination 8 Cladribine 8 Bortezomib 8 Antilymphocyte Serum 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05580861 2024-05-29

SALMA

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡